Japan withdraws recommendation of Merck and GSK HPV jabs – FierceVaccines

Japan withdraws recommendation of Merck and GSK HPV jabs
FierceVaccines
Japan takes a particularly reactive approach to vaccine adverse events. In 2011 Pfizer's ($PFE) Prevnar and Sanofi's ($SNY) ActHIB vaccines were both suspended following the deaths of four children. This week the spotlight is on GlaxoSmithKline ($GSK) 

and more »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *